Oncology Surgery Gynecology
Toulouse
Joined November 2020
- Tweets15
- Following92
- Followers57
- Likes59
Mathilde Del retweeted
Amazing presentation by Jessica McAlpine how opportunistic salpingectomy can reduce ovarian cancer incidence. 👏
Mathilde Del retweeted
Thank you @pedroramirezMD for the great podcasts! It’s a great way to stay updated and to learn from people with great experiences. Also thank you @agz_eriksson and @HsuMd. Am glad to be one of the @IJGCfellows and @IJGConline family and the @ENYGO_official family. – at Saint-Cloud, France
Mathilde Del retweeted
Repenser la prise en charge du cancer du col de stade avancé grâce à l’étude PAROLA.
Coordonné par le Pr Alejandra Martinez, l’essai clinique Parola (PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer) vient d’ouvrir aux inclusions. 1/3
Mathilde Del retweeted
Paper poster sessions at #ESGO22 : Today posters presented by Pr Alejandra Martinez, Dr Mathilde Del and Dr Martina Aida Angeles. The latter two are fellows of the Oncopole Surgical Oncology Training Program, ESGO accredited since 2017.
Mathilde Del retweeted
URGENT 🔴Déplacements du PSG : le club parisien annonce qu’il n’utilisera plus l’avion pour les matchs à domicile
Mathilde Del retweeted
Congratulations Anna, you owe it to your talent, passion and perseverance. Thanks to @AACR & @AstraZeneca for accompanying promising young fellows in establishing their careers and for supporting our research. #AACR22 #AACR2022 @crctoncopole @IUCTOncopoleICR @UT3PaulSabatier
#AACR22 | Dr. Anna Salvioni @IUCTOncopoleICR & @crctoncopole, just received the AACR-AstraZeneca Cancer Research Fellowship for her exciting project on the impact of Homologous Recombination Deficiency on T-cell exhaustion in ovarian cancer. @Astrazeneca @AACR
Mathilde Del retweeted
Totally by chance, from all male team members, one was at the lab meeting this morning. Can’t see him, he was behind the camera! #WomenInScience
Mathilde Del retweeted
«The #HPV immunisation programme has successfully almost eliminated #cervicalcancer in #women born since Sept 1, 1995»🇬🇧🙌🏼🇬🇧
#VaccinesWork @TheLancet @Kreftforeningen @CervicalUk #GynCancer @ESGO_society @ENYGO_official @JoTrust #gyncsm @OncoAlert
🔗thelancet.com/journals/lance… – at Oslo, Norway